ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
0.4616
+0.0166 (3.73%)
Jul 3, 2025, 4:00 PM - Market closed
ALX Oncology Holdings Stock Forecast
ALXO's stock price has decreased by -92.57% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 6 analysts that cover ALX Oncology Holdings stock have a consensus rating of "Strong Buy" and an average price target of $3.3, which forecasts a 614.9% increase in the stock price over the next year. The lowest target is $1 and the highest is $9.
Price Target: $3.3 (+614.9%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 21, 2025.
Analyst Ratings
The average analyst rating for ALX Oncology Holdings stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $1.2 → $1 | Strong Buy | Maintains | $1.2 → $1 | +116.64% | May 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $2 | Strong Buy | Maintains | $5 → $2 | +333.27% | May 9, 2025 |
| Stifel | Stifel | Hold Maintains $3 → $1.5 | Hold | Maintains | $3 → $1.5 | +224.95% | Mar 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +983.18% | Mar 7, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $8 → $9 | Buy | Maintains | $8 → $9 | +1,849.72% | Mar 6, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.82
from -2.58
EPS Next Year
-1.29
from -1.82
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.56 | -0.82 | -0.46 |
| Avg | -1.82 | -1.29 | -1.08 |
| Low | -1.99 | -1.70 | -1.97 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.